First-in-Human Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of Janus Kinase-1 Inhibitor PF-04965842 in Healthy Western and Japanese Subjects

NCT01835197 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

79

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: PF-04965842
DRUG: Placebo
DRUG: PF-04965842
DRUG: Placebo
DRUG: PF-04965842
DRUG: Placebo
DRUG: PF-04965842
DRUG: Placebo
DRUG: PF-04965842
DRUG: Placebo

Sponsor

Pfizer